Search results :

Medroxyprogesterone

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: G03AC06, G03DA02, L02AB02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Headache 9% - 16.5% x x x x x x x x
Discomfort 11.2% x x x
Nervousness postmarketing, 10.8% x x x x x x x x
Metrorrhagia 7% x x x x x
Dizziness 5.6% x x x x x x x x
Libido decreased 5.5% x x x x
Injection site reaction 5% x
Fatigue 4.2% x x x x x x x x
Haemorrhage postmarketing, 8.2% x x x x
Cramps of lower extremities 3.7% x x x x
Nausea 3.3% x x x x x x x x
Leukorrhea 2.9% x x x
Breast pain 2.8% x x x x x
Abdominal bloating 2.3% x x x x
Back pain 2.2% x x x x x x
Oedema 2.2% x x x x x x x
Amenorrhoea 2.1% - 6% x x x x x x x x
Weight increased 2% - 6% x x x x
Dysmenorrhoea 1.7% x x x
Depression 1.5% x x x x x x
Vaginal inflammation 1.2% x x x x x
Acne 1.2% x x x x x x
Alopecia 1.1% x x x x x x x
Rash 1.1% x x x x x x
Arthralgia 1% x x x x
Hot flush 1% x x x
Insomnia 1% x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x
Anaemia postmarketing x x x x
Angioedema postmarketing x x
Anovulation postmarketing x
Asthenia postmarketing x x x x
Asthma postmarketing x x x x
Mental disorder postmarketing x
Bone disorder postmarketing x
Breast cancer postmarketing x x
Breast disorder postmarketing x
Chest pain postmarketing x x x x
Infection postmarketing x x x x
Scleroderma postmarketing x x x x
Drowsiness postmarketing x x x
Dyspnoea postmarketing x x x x
Facial paralysis postmarketing x x x x
Body temperature increased postmarketing x x x x x x x
Gastrointestinal disorder postmarketing x
Cardiac disorder postmarketing x
Blood disorder postmarketing x x x x
Hirsutism postmarketing x x x x x x x
Hoarseness postmarketing x x x x
Hyperplasia postmarketing x x x x
Hypersensitivity postmarketing x x x x x x
Immune system disorder postmarketing x
Libido increased postmarketing x x x x
Jaundice postmarketing x x x x
Breast mass postmarketing x x x x
Chloasma postmarketing x x x x x
Neoplasm postmarketing x
Nervous system disorder postmarketing x
Oligomenorrhoea postmarketing x
Osteoporosis postmarketing x x x x
Paraesthesia postmarketing x x x x
Pruritus postmarketing x x x x
Pulmonary embolism postmarketing x x x x x x x x
Convulsion postmarketing x x
Skin disorder postmarketing x
Swelling postmarketing x x x x
Syncope postmarketing x x x x
Tachycardia postmarketing x x x x
Thrombophlebitis postmarketing x x x x x x x
Unintended pregnancy postmarketing x x x x
Urticaria postmarketing x x x x
Varicose vein postmarketing x x x
Angiopathy postmarketing x
Chills postmarketing x x x x
Body odor postmarketing x x x x
Breast discharge postmarketing x x
Deep vein thrombosis postmarketing x x x x
Glucose tolerance decreased postmarketing x x x
Injection site pain postmarketing x x x x x
Dry skin postmarketing x x x x
Digestion impaired postmarketing x x x x
Galactorrhoea postmarketing x x x x x x x x
Vaginal cyst postmarketing x x x x
Rectal haemorrhage postmarketing x x x x
Hepatobiliary disease postmarketing x
Cervix carcinoma postmarketing x x x x
Anaphylactoid reaction postmarketing x x x x x x
Osteoporotic fracture postmarketing x x x x
Paralysis postmarketing x x x x
Sweating increased postmarketing x x x
Blood and lymphatic system disorders postmarketing x
Dyspareunia postmarketing x x x
Excessive thirst postmarketing x x x x
Somnolence postmarketing x x x x
Abdominal cramps x
Abdominal distension x
Abdominal pain x x x x
Abscess x x
Anxiety x
Bronchitis x
Vaginal moniliasis x x
Uterine cervical erosion x x
Chorea x
Cushing's syndrome x
Cystitis x x
Diarrhoea x
Diplopia x
Embolism x x
Epilepsy x
Erythema multiforme x x
Erythema nodosum x x x
Extravasation x
Fibrocystic breast disease x
Gallbladder disorder x
Haemangioma x
Hypercalcaemia x
Hypocalcaemia x
Influenza x
Irritability x x
Jaundice neonatal x
Jaundice cholestatic x x x
Menorrhagia x
Myocardial infarction x
Nasopharyngitis x
Optic neuritis x x x
Pain in extremity x
Pancreatitis x
Pelvic pain x x
Pharyngitis x
Porphyrin metabolism disorder x
Premenstrual syndrome x
Sinusitis x
Cerebrovascular accident x
Thromboembolism x x
Thrombosis x x x
Erythema x
Upper respiratory tract infection x
Urinary tract infection x
Uterine leiomyoma x
Vomiting x
Cerebral thrombosis x
Vaginitis bacterial x
Migraine x
Menstruation irregular x x x x
Menometrorrhagia x
Anorgasmia x
Tenderness x
Superficial phlebothrombosis x
Dermatitis hemorrhagic x x x
Breast tenderness x x x x x
Fluid retention x x
Ectropion of cervix x
Cushingoid x
Exacerbation of asthma x
Endometrial cancer x
Blood pressure increased x x x x
Dementia x
Rash generalised x x x
Mass x
Raised liver function tests x
Retinal vascular thrombosis x
Ovarian cancer x
Mood alteration NOS x
Vaginal haemorrhage x
Loss of libido x
Bleeding breakthrough x x x x
Unspecified visual loss x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Medroxyprogesterone

Side effects:31
Source:BC Cancer

medroxyprogesterone

Side effects:35
Source:FDA Structured Product Label

MEDROXYPROGESTERONE

Side effects:40
Source:FDA Structured Product Label

MEDROXYPROGESTERONE

Side effects:70
Source:FDA Structured Product Label

MEDROXYPROGESTERONE

Side effects:74
Source:FDA Structured Product Label

MEDROXYPROGESTERONE

Side effects:73
Source:FDA Structured Product Label

medroxyprogesterone

Side effects:74
Source:FDA Structured Product Label

MEDROXYPROGESTERONE

Side effects:99
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label